RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy

Editors of Cancer Research and Treatment · 2026

Read RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy by Editors of Cancer Research and Treatment (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13404212.txt.

Description

Editors of Cancer Research and Treatment retracted a 2026-listed paper on a two-drug pairing against liver cancer cells, at the request of all its authors. A concern over image duplication was raised in March 2026. Some images were repeated inside the paper itself. One image also matched an image in a separate paper in a different journal.

The lead contact author owned up to the duplications and agreed the data could not be fully trusted. Every co-author backed the pull-back request. The editors weighed the case under world editor guidelines and chose to retract. They also told the other journal's editor and the lead author's institution head.

Catalog record

CREATOREditors of Cancer Research and Treatment
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1178
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13404212

Browse the full library · About the Tower of Babel